The purpose of this study is to evaluate the long term safety and tolerability of fostamatinib in patients in Asia with rheumatoid arthritis (RA).
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01640054?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30
